期刊文献+

硫化砷对人结肠癌细胞株HCT116生长及迁移能力的影响 被引量:5

Arsenic Sulfide Inhibits the Proliferation and Migration Ability of HCT116 Cells in Vitro
原文传递
导出
摘要 目的:研究硫化砷对人结肠癌细胞株HCT116迁移能力的影响及其作用机制。方法:以HCT116细胞为研究对象,通过MTT法观察硫化砷对肿瘤细胞活性及增殖能力的影响,通过划痕实验观察硫化砷处理后细胞的迁移能力。Western Blot、Real-time PCR检测硫化砷处理前后细胞内E-钙粘素、P53、Notch1蛋白的表达及相应mRNA水平的变化。结果:硫化砷对HCT116细胞有抑制增殖的作用,此作用随着剂量的增加而增强。选取无毒剂量的硫化砷(1μM)处理HCT116细胞24 h后,细胞的迁移能力降低了52.00%±7.55%。Western Blot及Real-time PCR结果显示,硫化砷处理后,HCT116细胞内的E-钙粘素蛋白水平及mRNA水平均明显升高,P53蛋白水平增高,但对Notch1蛋白及mRNA水平无明显影响。结论:一定剂量范围的硫化砷能抑制HCT116细胞增殖,并能降低其迁移能力。硫化砷降低HCT116细胞的迁移能力,其机制可能是通过上调P53蛋白的水平,从而增高E-钙粘素的表达实现的。 Objective: To investigate the role ofrealgar (As4S4) on regulating migration ability ofHCT116 cells in vitro. Methods: The cytotoxicity effect of As4S4 on HCT116 cells was observed by MTT assay. The effect of As454 on migration ability was observed by cell migration test. Expression of E-cadherin, P53 and Notchl protein and mRNA levels was determined by western blot assay and Real- time PCR assay. Results: The proliferation ofHCT116 cells was inhibited by AsaS4 in a dose -dependent manner. 1 IxM As454 showed no significant proliferation inhibition effect on HCTll6 cells. With this dose, As4S4 reduced the migration ability of HCTll6 cells by 52.00%+ 7.55%. AsaS4 treatment up-regulated the protein and mRNA levels of E-cadherin, up-regulated the protein level of P53, but showed no effect on Notchl. Conclusion: A$454 reduced the proliferation and migration ability ofHCT116 cells. Inhibition of the migra- tion ability probably caused by the up-regulation of P53 and E-cadherin.
出处 《现代生物医学进展》 CAS 2013年第19期3615-3618,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81274142 30300139) 上海市科委自然基金项目(11ZR1423400) 上海市教委重点项目(07zz43)
关键词 硫化砷 雄黄 HCT116 E-钙粘素 P53 迁移 As4S4 Realgar HCT116 E-cadherin P53 Migration
  • 相关文献

参考文献20

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Clin, 2011, 61(2):69-90. 被引量:1
  • 2Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07[J]. J Clin Oncol, 2007, 25(16):2198-2204. 被引量:1
  • 3Chen S, Fang Y, Ma L, et al. Realgar-induced apoptosis and differenti- ation in all-trans retinoic acid (ATRA)-sensitive NB4 and ATRA-re- sistant MR2 cells[J]. Int J Oncol, 2012, 40(4):1089-1096. 被引量:1
  • 4Wu J, Shao Y, Liu J, et al. The medicinal use of realgar (As4S4) and its recent development as an anticancer agent [J]. J Ethnopharmacol, 2011,135(3):595-602. 被引量:1
  • 5Qi J, He P, Chen W, et al. Comparative proteome study of apoptosis induced by As4S4 in retinoid acid resistant human acute promyelo- cytic leukemia NB4-R1 cells[J]. Leuk Res, 2010, 34(11): 1506-1516. 被引量:1
  • 6Evens AM, Tallman MS, Gartenhaus RB. The potential of arsenic tri- oxide in the treatment of malignant disease: past, present, and future [J]. Leuk Res, 2004, 28(9):891-900. 被引量:1
  • 7Yilmaz M, Christofofi G. EMT, the cytoskeleton, and cancer cell inva- sion[J]. Cancer Metastasis Rev, 2009, 28(1-2): 15-33. 被引量:1
  • 8Bastid J. EMT in carcinoma progression and dissemination: facts, unanswered questions, and clinical considerations [J]. Cancer Metas- tasis Rev, 2012, 31 ( 1-2):277-283. 被引量:1
  • 9Perl AK, Wilgenbus P, Dahl U, et al. A causal role for E-cadherin in the transition from adenoma to carcinoma [J]. Nature, i998, 392 (6672): 190-193. 被引量:1
  • 10Buda A, Pignatelli M. E-cadherin and the cytoskeletal network in col- orectal cancer development and metastasis [J]. Cell Commun Adhes, 2011, 18(6):133-143. 被引量:1

同被引文献183

引证文献5

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部